Pathstone Family Office, LLC Ionis Pharmaceuticals Inc Transaction History

Pathstone Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $20,277 - $30,423	-477 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $13,680 - $18,201	302 Added 172.57%	477 $27,000
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $5,012 - $6,532	-107 Reduced 37.94%	175 $11,000
Q1 2020 Jun 11, 2020	BUY	$41.6 - $63.4 $4,451 - $6,783	107 Added 61.14%	282 $14,000
Q1 2020 May 07, 2020	BUY	$41.6 - $63.4 $7,280 - $11,095	175 New	175 $8.27 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $9,065 - $12,576	-146 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $6,332 - $8,692	146 New	146 $8,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.